pKrox24(2xD-E_inD)Luc
(Plasmid
#200109)
-
PurposeLuciferase reporter for in cell monitoring of receptor tyrosine kinase-MAP ERK pathway activity
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 200109 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGL4.17
-
Backbone manufacturerPromega
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namemodified EGR1 promoter
-
SpeciesSynthetic
-
Mutationhighly modified sequence
- Promoter 2 copies of D-E element in front of EGR1 promoter fragment D, no other promoter elements
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site unknown (unknown if destroyed)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please Note: Plasmid contains an A to G nucleotide mutation in one of the three D elements of the EGR1D promoter and a three nucleotide insertion between the promoter and luciferase. These mutations are not known to affect plasmid function.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pKrox24(2xD-E_inD)Luc was a gift from Pavel Krejčí (Addgene plasmid # 200109 ; http://n2t.net/addgene:200109 ; RRID:Addgene_200109) -
For your References section:
One reporter for in-cell activity profiling of majority of protein kinase oncogenes. Gudernova I, Foldynova-Trantirkova S, Ghannamova BE, Fafilek B, Varecha M, Balek L, Hruba E, Jonatova L, Jelinkova I, Kunova Bosakova M, Trantirek L, Mayer J, Krejci P. Elife. 2017 Feb 15;6. pii: e21536. doi: 10.7554/eLife.21536. 10.7554/eLife.21536 PubMed 28199182